Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Coral Gables, FL
SEC filing record 1 source field available
Fiscal year end
31 December
RELMADA THERAPEUTICS, INC. has filed 598 SEC EDGAR filings since 13 Nov 2012

SEC filing history

Showing 201-225 of 598 matching filings.

Per page
25
Current page
9
4

4 filing

Filing date
05 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
01 Jun 2022
Reporting date
25 May 2022
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
17 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
05 May 2022
Reporting date
05 May 2022
Next action
Verify source filing
DEF 14A File 001-39082

PROXY STATEMENT

Filing date
11 Apr 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-264189

REGISTRATION STATEMENT

Filing date
07 Apr 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2022
Reporting date
04 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Apr 2022
Reporting date
01 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-39082

PROXY STATEMENT

Filing date
31 Mar 2022
Reporting date
31 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K File 001-39082

ANNUAL REPORT

Filing date
25 Mar 2022
Reporting date
31 Dec 2021
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
23 Mar 2022
Reporting date
23 Mar 2022
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
07 Mar 2022
Reporting date
07 Mar 2022
Next action
Verify source filing
8-K File 001-39082

CURRENT REPORT

Filing date
23 Feb 2022
Reporting date
23 Feb 2022
Next action
Verify source filing
SC 13G File 005-88207

SC 13G

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88207

RELMADA THERAPEUTICS, INC.

Filing date
14 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88207

RELMADA THERAPEUTICS, INC.

Filing date
11 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88207

SC 13G/A filing

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
05 Jan 2022
Reporting date
03 Jan 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .